SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018436
Filing Date
2024-05-09
Accepted
2024-05-09 16:15:58
Documents
56
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1826898
2 ex31-1.htm EX-31.1 13689
3 ex31-2.htm EX-31.2 13648
4 ex32-1.htm EX-32.1 8495
  Complete submission text file 0001493152-24-018436.txt   6020637

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gnlx-20240331.xsd EX-101.SCH 41684
6 XBRL CALCULATION FILE gnlx-20240331_cal.xml EX-101.CAL 43996
7 XBRL DEFINITION FILE gnlx-20240331_def.xml EX-101.DEF 163384
8 XBRL LABEL FILE gnlx-20240331_lab.xml EX-101.LAB 371056
9 XBRL PRESENTATION FILE gnlx-20240331_pre.xml EX-101.PRE 264284
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 724967
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41599 | Film No.: 24930885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)